Search

everythinglearnresearchcommunity

for

Search:↓

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

The research identified unique metabolic activities in immune cells associated with hair loss in Alopecia Areata.

Hair color is not a risk factor for developing alopecia areata.

New treatments for alopecia are being explored due to the limitations of current options.

Gut bacteria differences may help diagnose and treat Alopecia areata.

JAK inhibitors offer new hope for treating severe alopecia areata.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Future hair loss treatments should aim to extend hair growth, reactivate resting follicles, reverse shrinkage, and possibly create new follicles, with gene therapy showing promise.

The Chinese herbal supplement BeauTop can potentially boost hair growth and thickness by increasing a protein called Vascular Endothelial Growth Factor.

The microneedle patch with quercetin, zinc, and copper effectively promotes hair regrowth for androgenic alopecia.

Finasteride helps female-pattern hair loss.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.

Frontal fibrosing alopecia may be linked to genital Lichen sclerosus through an autoimmune process.

CD8+ T cells attack hair follicle stem cells, causing scarring and hair loss.

Eating vitamin A affects hair growth and health by changing cell signals in mice.

The study found that a key immune pathway protecting hair follicles is reduced in a mouse model of scarring hair loss.

A man's skin cancer improved and some of his hair grew back after treatment with a special light therapy and a medication.

Hair graying is influenced by factors like nerves, fat cells, and immune cells, not just hair follicles.

Higher miR-34a levels and the A variant of the MIR-34A gene are linked to increased risk and severity of alopecia areata.

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Ginsenoside CK, found in Panax ginseng, can prevent hair loss by controlling certain growth pathways and promoting hair follicle development.